— Know what they know.
Not Investment Advice

INLB OTC

Item 9 Labs Corp.
1W: -99.0% 1M: -99.0% 3M: -99.0% YTD: -99.0% 1Y: -99.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±4955.7%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $70181 mcap · 524M float · 0.0039% daily turnover

Cash Flow Trends

Operating Cash Flow
-$2M +62.4% ▲
Capital Expenditures
$5M -143.4% ▼
Free Cash Flow
-$8M +6.3% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$1M -199.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$642K-$10M-$12M-$11M-$31M
Depreciation & Amort.$50K$676K$979K$1M$2M
Stock-Based Comp.$104K$234K$335K$2M$3M
Change in Working Capital-$468K-$261K$3M-$3M$8M
Other Non-Cash Items$85K$771K$6M$5M$16M
Operating Cash Flow-$976K-$2M-$1M-$6M-$2M
— Investing Activities —
Capital Expenditures-$543K-$6M-$406K-$2M-$4M
Acquisitions (Net)$88K-$1M-$556K-$2M-$138K
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$79K$115K$75K$5K-$695K
Investing Cash Flow-$375K-$8M-$887K-$4M-$5M
— Financing Activities —
Net Debt Issuance$2M$3K$2M-$2M$6M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$1M$9M$0-$19K-$54K
Financing Cash Flow$2M$9M$2M$11M$6M
Net Change in Cash$160K-$1M-$490K$1M-$1M
Cash End of Period$174K$575K$85K$1M$86K
Free Cash Flow-$2M-$9M-$2M-$8M-$8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms